Cargando…

Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus

Background and Objectives: Belimumab (BEL) is a monoclonal antibody approved for the treatment of active systemic lupus erythematosus (SLE) but not for lupus nephritis (LN) and neuropsychiatric systemic lupus erythematosus (NPSLE). We aimed to assess BEL's effects on these severe, potentially l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plüß, Marlene, Tampe, Björn, Niebusch, Noah, Zeisberg, Michael, Müller, Gerhard A., Korsten, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267006/ https://www.ncbi.nlm.nih.gov/pubmed/32537456 http://dx.doi.org/10.3389/fmed.2020.00222

Ejemplares similares

Therapeutic Implications of Renal Biopsies to Detect Proliferative Lupus Nephritis in Patients With Low-Grade Proteinuria
por: Plüß, Marlene, et al.
Publicado: (2020)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments
por: Korsten, Peter, et al.
Publicado: (2019)

Histopathological Findings Predict Renal Recovery in Severe ANCA-Associated Vasculitis Requiring Intensive Care Treatment
por: Hakroush, Samy, et al.
Publicado: (2021)

A Transcriptome Array-Based Approach Links Proteinuria and Distinct Molecular Signatures to Intrarenal Expression of Type I Interferon IFNA5 in Lupus Nephritis
por: Korsten, Peter, et al.
Publicado: (2023)

Proteinuria Indicates Decreased Normal Glomeruli in ANCA-Associated Glomerulonephritis Independent of Systemic Disease Activity
por: Tampe, Désirée, et al.
Publicado: (2021)

The Role of Belimumab in Systemic Lupus Erythematosis: A Systematic Review
por: Joy, Ashna, et al.
Publicado: (2022)

Editorial: Multidisciplinary critical care medicine – Getting things done across specialties
por: Korsten, Peter, et al.
Publicado: (2023)

Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis
por: Baum, Rebecca, et al.
Publicado: (2023)

An update on belimumab for the treatment of lupus
por: Thanou-Stavraki, Aikaterini, et al.
Publicado: (2011)

Belimumab in systemic lupus erythematosus
por: Vilas-Boas, Andreia, et al.
Publicado: (2015)

Belimumab in Systemic Lupus Erythematosus
por: Srivastava, Ankita
Publicado: (2016)

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
por: Wise, Leanna M., et al.
Publicado: (2020)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis
por: Frieri, Marianne, et al.
Publicado: (2015)

Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab—A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic Approach
por: Plüß, Marlene, et al.
Publicado: (2022)

Different Patterns of Kidney Fibrosis Are Indicative of Injury to Distinct Renal Compartments
por: Tampe, Désirée, et al.
Publicado: (2021)

Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus Erythematosus
por: Struemper, Herbert, et al.
Publicado: (2017)

Systemic Lupus Erythematosus-Associated Serositis Managed With Intravenous Belimumab: A Case Report
por: Mukkera, Srikanth, et al.
Publicado: (2022)

Hemodiafiltration Treatment for Severe Valproic Acid Intoxication: Case Report and Updated Systematic Literature Review
por: Tichelbäcker, Tobias, et al.
Publicado: (2018)

Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

The "rapid atrial swirl sign" for assessing central venous catheters: Performance by medical residents after limited training
por: Korsten, Peter, et al.
Publicado: (2018)

Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes
por: Korsten, Peter, et al.
Publicado: (2021)

Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition
por: Hakroush, Samy, et al.
Publicado: (2021)

Primary cilia modulate balance of canonical and non-canonical Wnt signaling responses in the injured kidney
por: Saito, Shoji, et al.
Publicado: (2015)

Update zu: COVID-19 und die Niere – Klinik
por: Böckhaus, Jan, et al.
Publicado: (2021)

Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus
por: Bortoluzzi, Alessandra, et al.
Publicado: (2018)

Comparative analysis of SGLT-2 expression in renal vasculitis and lupus nephritis
por: Hakroush, Samy, et al.
Publicado: (2022)

Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
por: Dimelow, Richard, et al.
Publicado: (2020)

Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2
por: Plüß, Marlene, et al.
Publicado: (2022)

Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM
por: Plüß, Marlene, et al.
Publicado: (2022)

Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease
por: Tampe, Björn, et al.
Publicado: (2014)

Pharmacogenetic analysis of belimumab fails to identify robust genetic predictors of efficacy in lupus
por: St Jean, Pamela L., et al.
Publicado: (2019)

Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
por: D’Alessandro, Roberto, et al.
Publicado: (2021)

Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus
por: Miyazaki, Yusuke, et al.
Publicado: (2021)

The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review
por: Abid, Naushad, et al.
Publicado: (2023)

Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma
por: Plüß, Marlene, et al.
Publicado: (2022)

Acute Pancreatitis After the Use of Belimumab in a Patient With Systemic Lupus Erythematosus: Case Report and Review of Literature
por: Bazigh, Izza, et al.
Publicado: (2022)

Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
por: Barrett, Christine, et al.
Publicado: (2020)

New treatment options for lupus – a focus on belimumab
por: Chiche, Laurent, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6dunplcklsnr6tvtjg4dptgce5